Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-05-07 | 2021-05-26 | 138954 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2021-05-14 | 2021-05-26 | 139400 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2021-08-27 | 2021-11-19 | 144656 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2021-10-01 | 2021-11-15 | 146500 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-10-29 | 2021-11-08 | 148491 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-02-04 | 2022-04-01 | 154168 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155308 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2022-06-06 | 2022-07-22 | 162088 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-06-06 | 2022-07-22 | 162091 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-06-12 | 2022-07-22 | 162469 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2022-12-02 | 2023-03-02 | 176924 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-12-16 | 2023-03-02 | 178793 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2023-02-02 | 2023-03-02 | 183486 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 5MG | TABLET | Resolved | 2023-02-16 | 2023-03-02 | 185022 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-02-16 | 2023-03-02 | 185025 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2023-07-07 | 2023-09-01 | 197872 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212940 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2024-02-16 | 2024-06-07 | 219843 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229404 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |